Russell Investments Group, Ltd. Ionis Pharmaceuticals Inc Transaction History
Russell Investments Group, Ltd.
- $66.8 Billion
- Q3 2024
A detailed history of Russell Investments Group, Ltd. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 128,469 shares of IONS stock, worth $4.78 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
128,469
Previous 132,736
3.21%
Holding current value
$4.78 Million
Previous $6.33 Million
18.65%
% of portfolio
0.01%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding IONS
# of Institutions
400Shares Held
136MCall Options Held
882KPut Options Held
476K-
Vanguard Group Inc Valley Forge, PA15.1MShares$561 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$527 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$384 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$325 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$293 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.28B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...